# Flash Radiotherapy for Skin Cancer

Source: https://onco.cc/trials/nct07455331/  
OnCo record `nct07455331` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of FLASH radiotherapy in Cutaneous squamous cell carcinoma and Basal cell carcinoma, run by Jules Bordet Institute, not yet recruiting.

## Summary

Flash Radiotherapy for Skin Cancer is a phase 2 interventional study registered as NCT07455331 by Jules Bordet Institute, with 60 participants planned, started 2026-06-23 and due to reach its primary completion in 2029-12-23. Interventions recorded: FLASH radiotherapy, Conventional radiotherapy. Conditions recorded: Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC).

Linked to the technology FLASH radiotherapy because the registry names it ("flash radiotherapy") among its interventions and Cutaneous squamous cell carcinoma and Basal cell carcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07455331
- Phase: 2
- Setting: Randomized Phase II Selection Trial of FLASH Versus Conventional Radiotherapy for Participants With Localized Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
- Sponsor: Jules Bordet Institute
- Enrolled: 60

## Sources

- ClinicalTrials.gov NCT07455331: https://clinicaltrials.gov/study/NCT07455331

## Connected records

- cancers: [Basal cell carcinoma](https://onco.cc/cancers/basal-cell-carcinoma/), [Cutaneous squamous cell carcinoma](https://onco.cc/cancers/cutaneous-scc/)
- technologies: [FLASH radiotherapy](https://onco.cc/technologies/flash-rt/)

---
JSON: https://onco.cc/api/v1/entities/nct07455331.json